Showing results (811-820 of 876) with videos related to

Sort By:
Pageof 88
Injury|September 24, 2024
Wound infection rate after skin closure of damage control laparotomy with wicks or incisional negative wound therapy: An EAST multi-center trialJohn Cull, Katherine Pellizzeri, Daniel C Cullinane, et al.
Public Health Research (Southampton, England)|July 28, 2026
Evaluation of planning policy to regulate takeaway food outlets for improved health in England: SynopsisThomas Burgoine, Jean Adams, Ben Amies-Cull, et al.
Chemical Science|January 13, 2025
Evolution of amorphous ruthenium nanoclusters into stepped truncated nano-pyramids on graphitic surfaces boosts hydrogen production from ammoniaYifan Chen, Benjamin J Young, Gazi N Aliev, et al.
International Journal of Health Geographics|November 10, 2024
Development of an approach to forecast future takeaway outlet growth around schools and population exposure to takeaways in EnglandBochu Liu, Oliver Mytton, John Rahilly, et al.
Journal of Vascular Surgery|August 17, 2005
Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patientsSpence M Taylor, Corey A Kalbaugh, Dawn W Blackhurst, et al.
Journal of Vascular Surgery|June 12, 2004
Invasive treatment of chronic limb ischemia according to the Lower Extremity Grading System (LEGS) score: a 6-month reportCorey A Kalbaugh, Spence M Taylor, David L Cull, et al.
Clinical Science (London, England : 1979)|July 23, 2021
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertensionDaniel N Meijles, Joshua J Cull, Susanna T E Cooper, et al.
ACS Nano|January 22, 2024
Atomic-Scale Time-Resolved Imaging of Krypton Dimers, Chains and Transition to a One-Dimensional GasIan Cardillo-Zallo, Johannes Biskupek, Sally Bloodworth, et al.
Cytotherapy|August 13, 2002
Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusionR J Lush, A P Haynes, J Byrne, et al.
Blood|July 23, 2020
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-upJudith Trotman, Stephen Opat, David Gottlieb, et al.
Pageof 88